{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:26:26Z","timestamp":1789579586207,"version":"build-2803163510"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Cardiovascular-kidney-metabolic (CKM) syndrome represents a syndromic continuum encompassing overlapping cardiovascular, kidney, and metabolic dysfunction. Hypertension is a central driver in the pathogenesis of CKM syndrome, promoting both kidney and metabolic deterioration, but little is known about the benefits of intensive blood pressure (BP) control across CKM syndrome stages.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate CKM syndrome stage\u2013specific outcomes, safety, and net clinical benefits associated with a comprehensive intensive BP intervention.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This is a post hoc, secondary analysis of a cluster randomized clinical trial, the China Rural Hypertension Control Project (CRHCP), which was conducted between May 2018 and March 2023. Participants were adults aged 40 years or older with hypertension and CKM syndrome stages 2 to 4, which were defined using standard criteria. Stage 2 indicates that the patient has a metabolic risk factor; stage 3, subclinical cardiovascular disease or predicted 10-year risk of 20% or greater; and stage 4, clinical cardiovascular disease. In this analysis, participants had a median (IQR) follow-up of 3.02 (2.97-3.06) years. Data analysis was conducted from November 2024 to June 2025.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n The comprehensive BP control strategy targeted a systolic BP less than 130 mm Hg and a diastolic BP less than 80 mm Hg. The intervention was delivered by trained nonphysician practitioners.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary clinical outcome was a composite of major adverse cardiovascular events (stroke, myocardial infarction, heart failure, or cardiovascular death). Safety outcomes included hypotension, syncope, injurious falls, and kidney adverse events. A quantitative benefit-harm analysis was conducted to estimate net benefit associated with the intervention.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 33\u202f736 participants (mean [SD] age, 63.0 [9.2] years; 20\u202f677 [61.3%] women), 18\u202f662 (55.3%) had stage 2 CKM syndrome (of whom 9526 [51.0%] received the intervention), 7984 (23.7%) had stage 3 (of whom 4032 [50.5%] received the intervention), and 7090 (21.0%) had stage 4 (of whom 3713 [52.4%] received the intervention). Treatment outcomes were generally consistent across CKM syndrome stages. Intensive BP control was associated with reduced cardiovascular events across all stages: in stage 2, the hazard ratio (HR) was 0.61 (95% CI, 0.50-0.73); in stage 3, the HR was 0.71 (95% CI, 0.58-0.84); and in stage 4, the HR was 0.67 (95% CI, 0.58-0.76). The risk of all-cause mortality was also lower in stage 2 (HR, 0.73; 95% CI, 0.57-0.90) and stage 3 (HR, 0.82; 95% CI, 0.68-0.96) but not in stage 4 (HR, 1.02; 95% CI, 0.84-1.20). Risk of hypotension increased across all stages (relative risk range, 1.79-2.34), while other adverse events, including kidney events, were similar between groups, despite some numerical variation across stages. Net benefits were favorable: stage 2, 1.58 (95% CI, 1.53-1.62); stage 3, 2.53 (95% CI, 2.42-2.64); and stage 4, 2.15 (95% CI, 2.04-2.26).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this post hoc analysis of a cluster randomized clinical trial, a comprehensive intervention targeting BP less than 130\/80 mm Hg demonstrated a favorable benefit-to-harm profile across CKM syndrome stages, with no clear heterogeneity across CKM syndrome stages. These findings provide the first trial-based evidence to guide CKM syndrome management and support scalable strategies for this high-risk, multimorbid population.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT03527719<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.57180","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:30:18Z","timestamp":1771000218000},"page":"e2557180","source":"Crossref","is-referenced-by-count":2,"title":["Intensive Blood Pressure Control and Cardiovascular Outcomes Across Cardiovascular-Kidney-Metabolic Syndrome Stages"],"prefix":"10.1001","volume":"9","author":[{"given":"Xiaofan","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Evidence-Based Medicine, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhe","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhi","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhua","family":"He","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengling","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Record Management Center, the First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"20","key":"zoi251522r1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association.","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"zoi251522r2","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US Renal Data System 2020 Annual Data Report: epidemiology of kidney disease in the United States.","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"zoi251522r3","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20132020 update: a report from the American Heart Association.","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"18","key":"zoi251522r4","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.2021.5469","article-title":"The leading causes of death in the US for 2020.","volume":"325","author":"Ahmad","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"zoi251522r5","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal, and metabolic disorders: a narrative review with a focus on Japan.","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"21","key":"zoi251522r6","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US Adults, 2011-2020.","volume":"331","author":"Aggarwal","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"zoi251522r7","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jacasi.2025.04.007","article-title":"Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in China: a nationwide population-based study.","volume":"5","author":"Zheng","year":"2025","journal-title":"JACC Asia"},{"issue":"19","key":"zoi251522r8","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10285","key":"zoi251522r9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.","volume":"397","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"zoi251522r10","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as cardiovascular risk factor in chronic kidney disease.","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ Res"},{"key":"zoi251522r11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1475-2840-8-51","article-title":"Blood pressure control and components of the metabolic syndrome: the GOOD survey.","volume":"8","author":"Zidek","year":"2009","journal-title":"Cardiovasc Diabetol"},{"issue":"38","key":"zoi251522r12","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension.","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"zoi251522r13","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension\u2014The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"10380","key":"zoi251522r14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"issue":"10339","key":"zoi251522r15","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0140-6736(22)00325-7","article-title":"A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial.","volume":"399","author":"Sun","year":"2022","journal-title":"Lancet"},{"issue":"22","key":"zoi251522r16","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control.","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"zoi251522r17","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension.","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi251522r18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence.","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"zoi251522r19","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.5551\/jat.21_Sup.1-S31","article-title":"Metabolic syndrome and cardiovascular diseases in Korea.","volume":"21","author":"Suh","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"zoi251522r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101474","article-title":"Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011-2021: a representative longitudinal serial study.","volume":"55","author":"Yim","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"zoi251522r21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12955-019-1250-6","article-title":"Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling.","volume":"17","author":"Aschmann","year":"2019","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"zoi251522r22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028438","article-title":"Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment.","volume":"9","author":"Aschmann","year":"2019","journal-title":"BMJ Open"},{"issue":"5","key":"zoi251522r23","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/jgs.19395","article-title":"Individualized net benefit of intensive blood pressure lowering among community-dwelling older adults in SPRINT.","volume":"73","author":"Jamshidian","year":"2025","journal-title":"J Am Geriatr Soc"},{"issue":"16","key":"zoi251522r24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.033995","article-title":"Incorporating individual-level treatment effects and outcome preferences into personalized blood pressure target recommendations.","volume":"13","author":"Ascher","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"zoi251522r25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41746-019-0156-3","article-title":"Translating clinical trial results into personalized recommendations by considering multiple outcomes and subjective views.","volume":"2","author":"Dagan","year":"2019","journal-title":"NPJ Digit Med"},{"issue":"1","key":"zoi251522r26","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1186\/s12889-025-22865-3","article-title":"Cardiovascular-kidney-metabolic syndrome modifies smoking-related risk for cardiovascular diseases: findings from an observational cohort study in UK Biobank.","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Public Health"},{"key":"zoi251522r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100985","article-title":"Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: a prospective cohort study.","volume":"22","author":"Li","year":"2025","journal-title":"Am J Prev Cardiol"},{"issue":"7","key":"zoi251522r28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.0000000637","article-title":"Cumulative incidence of mortality associated with cardiovascular-kidney-metabolic (CKM) syndrome.","volume":"36","author":"Claudel","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"zoi251522r29","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1594041","article-title":"Association of neutrophil\/high-density lipoprotein cholesterol ratio with the cardiovascular-kidney-metabolic syndrome and its cardiovascular mortality.","volume":"12","author":"Xu","year":"2025","journal-title":"Front Nutr"},{"issue":"13","key":"zoi251522r30","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurjpc\/zwaf248","article-title":"Association between remnant cholesterol and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study.","volume":"32","author":"Ding","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"zoi251522r31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12933-025-02754-0","article-title":"Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study.","volume":"24","author":"Lu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"zoi251522r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.45309","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health.","volume":"7","author":"Zhu","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi251522r33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036820","article-title":"Intensive blood pressure strategy on cardiovascular diseases in patients with metabolic syndrome: post hoc analysis of a clinical trial.","volume":"14","author":"Sun","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"zoi251522r34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036719","article-title":"Effect of intensive blood pressure control and comorbidity status on the prognosis of patients with hypertension: insights from SPRINT.","volume":"14","author":"Zheng","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"zoi251522r35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.037712","article-title":"Educational attainment and the effect of intensive blood pressure reduction: a post hoc analysis of the SPRINT Study.","volume":"14","author":"Garfein","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"zoi251522r36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12933-025-02735-3","article-title":"Life\u2019s Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China.","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"zoi251522r37","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.118585","article-title":"Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality.","volume":"397","author":"Li","year":"2024","journal-title":"Atherosclerosis"},{"issue":"6","key":"zoi251522r38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004629","article-title":"Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: a retrospective cohort study.","volume":"22","author":"Tsai","year":"2025","journal-title":"PLoS Med"},{"issue":"4","key":"zoi251522r39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hfc.2019.06.007","article-title":"Hypertension and heart failure.","volume":"15","author":"Slivnick","year":"2019","journal-title":"Heart Fail Clin"},{"issue":"4","key":"zoi251522r40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/HCO.0000000000000852","article-title":"Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?","volume":"36","author":"Myhre","year":"2021","journal-title":"Curr Opin Cardiol"},{"issue":"17","key":"zoi251522r41","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/CIRCULATIONAHA.116.025322","article-title":"Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the United States: projections from NHANES (National Health and Nutrition Examination Survey).","volume":"135","author":"Bress","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"zoi251522r42","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes.","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi251522r43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.117.10713","article-title":"Intensive blood pressure targets for diabetic and other high-risk populations: a pooled individual patient data analysis.","volume":"71","author":"Aggarwal","year":"2018","journal-title":"Hypertension"},{"key":"zoi251522r44","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.2337\/dcS15-3020","article-title":"Specific blood pressure targets for patients with diabetic nephropathy?","volume":"39","author":"Grassi","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"zoi251522r45","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/jamainternmed.2017.0197","article-title":"Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis.","volume":"177","author":"Tsai","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"10","key":"zoi251522r46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11886-020-01365-3","article-title":"Intensive BP control and eGFR declines: are these events due to hemodynamic effects and are changes reversible?","volume":"22","author":"Chen","year":"2020","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"zoi251522r47","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jamda.2018.11.003","article-title":"Orthostatic hypotension and falls in older adults: a systematic review and meta-analysis.","volume":"20","author":"Mol","year":"2019","journal-title":"J Am Med Dir Assoc"},{"issue":"20","key":"zoi251522r48","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association.","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"zoi251522r49","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.cmet.2023.10.015","article-title":"Cardiovascular-kidney-metabolic syndrome: a step toward multidisciplinary and inclusive care.","volume":"35","author":"Claudel","year":"2023","journal-title":"Cell Metab"},{"issue":"21","key":"zoi251522r50","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1001\/jama.2023.22276","article-title":"Here\u2019s what to know about cardiovascular-kidney-metabolic syndrome, newly defined by the AHA.","volume":"330","author":"Larkin","year":"2023","journal-title":"JAMA"},{"issue":"16","key":"zoi251522r51","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034996","article-title":"Social risk profile and cardiovascular-kidney-metabolic syndrome in US Adults.","volume":"13","author":"Li","year":"2024","journal-title":"J Am Heart Assoc"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2845053\/guo_2026_oi_251522_1772734196.97481.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:00:32Z","timestamp":1772737232000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2845053"}},"subtitle":["A Post Hoc Analysis of the China Rural Hypertension Control Project"],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.57180","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}